Anti-CD62L抗体[MEL-14] (PE/Cy7 ®) (ab25569)


  • 产品名称Anti-CD62L抗体[MEL-14] (PE/Cy7 ®)
    参阅全部 CD62L 一抗
  • 描述
    大鼠单克隆抗体[MEL-14] to CD62L (PE/Cy7 ®)
  • 偶联物PE/Cy7 ®. Ex: 496nm, Em: 774nm
  • 特异性ab25569 recognises CD62L.
  • 经测试应用适用于: Functional Studies, Flow Cyt, IHC-Fr, IP, Blocking, Inhibition Assaymore details
  • 种属反应性
    与反应: Mouse
  • 免疫原

    Tissue/ cell preparation: C3H/eb cloned mouse B lymphoma 38C-13.

  • 常规说明This product or portions thereof is manufactured under license from Carnegie Mellon University under U.S. Patent Number 5,268,486 and related patents. Cy and CyDye are trademarks of GE Healthcare Limited.



Our Abpromise guarantee covers the use of ab25569 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
Functional Studies Use at an assay dependent concentration. Note: ab25569 can be used for cytotoxicity studies.
Flow Cyt Use 0.1µg for 106 cells. ab154460-Rat monoclonal IgG2a, is suitable for use as an isotype control with this antibody.
IHC-Fr Use at an assay dependent concentration.
IP Use at an assay dependent concentration.
Blocking Use at an assay dependent concentration. Ab25569 can be used to block in vitro binding of lymphocytes to peripheral lymph node HEV.
Inhibition Assay Use at an assay dependent concentration. Ab25569 inhibits in vivo lymphocyte extravasation into peripheral lymph nodes and the late stages of leukocyte rolling.


  • 功能Cell surface adhesion protein. Mediates the adherence of lymphocytes to endothelial cells of high endothelial venules in peripheral lymph nodes. Promotes initial tethering and rolling of leukocytes in endothelia.
  • 组织特异性Expressed in B cell lines and T lymphocytes.
  • 序列相似性Belongs to the selectin/LECAM family.
    Contains 1 C-type lectin domain.
    Contains 1 EGF-like domain.
    Contains 2 Sushi (CCP/SCR) domains.
  • 细胞定位Membrane.
  • Information by UniProt
  • 数据库链接
  • 别名
    • A.11 antibody
    • AI528707 antibody
    • CD62 antigen ligand antibody
    • CD62 antigen-like family member L antibody
    • CD62L antibody
    • gp90-MEL antibody
    • IgA nephropathy, susceptibility to, included antibody
    • L Selectin antibody
    • L-selectin antibody
    • LAM-1 antibody
    • LAM1 antibody
    • LECAM1 antibody
    • LEU8 antibody
    • Leukocyte adhesion molecule 1 antibody
    • Leukocyte surface antigen Leu-8 antibody
    • Leukocyte-endothelial cell adhesion molecule 1 antibody
    • Lnhr antibody
    • LSEL antibody
    • Ly-22 antibody
    • Ly-m22 antibody
    • Lyam-1 antibody
    • LYAM1 antibody
    • LYAM1_HUMAN antibody
    • Lymph node homing receptor antibody
    • Lymphocyte adhesion molecule 1 antibody
    • Lymphocyte antigen 22 antibody
    • Lymphocyte surface MEL-14 antigen antibody
    • MEL-14 antibody
    • Pln homing receptor antibody
    • PLNHR antibody
    • Selectin L antibody
    • Selectin, lymphocyte antibody
    • SELL antibody
    • TQ1 antibody
    see all

Anti-CD62L antibody [MEL-14] (PE/Cy7 ®) (ab25569)参考文献

This product has been referenced in:
  • Quinn KM  et al. Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization. J Immunol 190:2720-35 (2013). Mouse . Read more (PubMed: 23390298) »
  • Quinn KM  et al. Coadministration of polyinosinic:polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunity. J Immunol 191:5085-96 (2013). ICC/IF . Read more (PubMed: 24089189) »

See all 3 Publications for this product

Product Wall

Abcam guarantees this product to work in the species/application used in this Abreview.
Application Flow Cytometry
Sample Mouse Cell (whole blood)
Specification whole blood
Fixation none
Permeabilization No
Gating Strategy monocyte, lymphocyte and granulocyte

Abcam user community

Verified customer

提交于 May 01 2012